Sale!

Spinal Muscular Atrophy Carrier Screening Test Cost

Original price was: 3,000 د.إ.Current price is: 2,250 د.إ.

-25%

Spinal Muscular Atrophy (SMA) is a genetic disorder characterized by weakness and wasting in muscles used for movement. It occurs due to the loss of nerve cells called motor neurons in the spinal cord and the brainstem, leading to severe and progressive muscle wasting and weakness. Early detection and intervention can significantly impact the quality of life, making carrier screening an essential step for individuals planning to start a family.

The SMA Carrier Screening Test is a genetic test designed to identify individuals who carry a copy of the mutated gene responsible for Spinal Muscular Atrophy. Being a carrier means that the individual does not typically show symptoms of SMA but has a chance of passing the gene to their offspring. The test is particularly recommended for those with a family history of SMA or those in ethnic groups with a higher carrier frequency.

At DNA Labs UAE, the SMA Carrier Screening Test is available for individuals seeking to understand their carrier status. The test cost is 2250 AED and involves a simple and non-invasive procedure. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure accurate and reliable results, providing crucial information for family planning decisions. The facility is committed to maintaining confidentiality and providing professional genetic counseling to help interpret the test results and understand the potential implications for family planning.

Description

Spinal Muscular Atrophy Carrier screening Test

Test Name: Spinal Muscular Atrophy Carrier screening Test

Components: EDTA Vacutainer (2ml)

Price: 2250.0 AED

Sample Condition: Peripheral blood

Report Delivery: 7-10 days

Method: MLPA

Test type: Genetics

Doctor: Oncology

Test Department:

Pre Test Information: Spinal Muscular Atrophy Carrier screening can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

Spinal Muscular Atrophy (SMA) carrier screening is a genetic test that can determine if an individual is a carrier for the SMA gene. SMA is a rare genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. Carrier screening for SMA is typically recommended for individuals who are planning to have children or are pregnant. It can help identify individuals who carry a copy of the SMA gene but do not have symptoms of the disorder themselves. If both parents are carriers, there is a 25% chance of having a child with SMA.

The screening test usually involves a blood or saliva sample, which is then analyzed in a laboratory to determine if the individual carries the SMA gene. The test looks for changes or mutations in the SMN1 gene, which is responsible for producing a protein that is essential for the survival of motor neurons.

If a person is found to be a carrier for SMA, they can then discuss their reproductive options with a genetic counselor or healthcare provider. These options may include prenatal testing, in vitro fertilization with preimplantation genetic diagnosis, or adoption.

It is important to note that carrier screening for SMA is not typically included in routine prenatal genetic testing, so individuals who are interested in being screened should discuss it with their healthcare provider.

Test Name	Spinal Muscular Atrophy Carrier screening Test
Components	EDTA Vacutainer (2ml)
Price	2250.0 AED
Sample Condition	Peripheral blood
Report Delivery	7-10 days
Method	MLPA
Test type	Genetics
Doctor	Oncology
Test Department:
Pre Test Information	Spinal Muscular Atrophy Carrier screening can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	Spinal Muscular Atrophy (SMA) carrier screening is a genetic test that can determine if an individual is a carrier for the SMA gene. SMA is a rare genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. Carrier screening for SMA is typically recommended for individuals who are planning to have children or are pregnant. It can help identify individuals who carry a copy of the SMA gene but do not have symptoms of the disorder themselves. If both parents are carriers, there is a 25% chance of having a child with SMA. The screening test usually involves a blood or saliva sample, which is then analyzed in a laboratory to determine if the individual carries the SMA gene. The test looks for changes or mutations in the SMN1 gene, which is responsible for producing a protein that is essential for the survival of motor neurons. If a person is found to be a carrier for SMA, they can then discuss their reproductive options with a genetic counselor or healthcare provider. These options may include prenatal testing, in vitro fertilization with preimplantation genetic diagnosis, or adoption. It is important to note that carrier screening for SMA is not typically included in routine prenatal genetic testing, so individuals who are interested in being screened should discuss it with their healthcare provider.